The role of atrial sensing for new‐onset atrial arrhythmias diagnosis and management in single‐chamber implantable cardioverter‐defibrillator recipients: Results from the THINGS registry
暂无分享,去创建一个
M. Biffi | M. Ziacchi | D. Saporito | G. Boggian | M. Iori | E. de Maria | V. Carinci | V. Calvi | E. Ammendola | D. Giacopelli | A. Placci | G. Statuto | D. Grassini | M. Bolognesi | G. Allocca | E. De Maria
[1] A. Capucci,et al. Are Atrial High-Rate Episodes Associated With Increased Risk of Ventricular Arrhythmias and Mortality? , 2019, JACC. Clinical electrophysiology.
[2] Daniel Y. Choi,et al. Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter‐defibrillator systems: Results of the SENSE trial , 2019, Journal of cardiovascular electrophysiology.
[3] Mintu P Turakhia,et al. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation. , 2019, Circulation.
[4] A. Auricchio,et al. Estimating the incidence of atrial fibrillation in single‐chamber implantable cardioverter defibrillator patients , 2018, Pacing and clinical electrophysiology : PACE.
[5] T. Reinhold,et al. Cost Saving Potential of an Early Detection of Atrial Fibrillation in Patients after ICD Implantation , 2018, BioMed research international.
[6] A. Capucci,et al. Does the CHA2DS2-VASc score reliably predict atrial arrhythmias? Analysis of a nationwide database of remote monitoring data transmitted daily from cardiac implantable electronic devices. , 2018, Heart rhythm.
[7] Rajiv Mahajan,et al. Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis , 2018, European heart journal.
[8] L. Jordaens,et al. Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.
[9] C. Valzania,et al. Less is more: Can we achieve cardiac resynchronization with 2 leads only? , 2017, International journal of cardiology.
[10] L. Fauchier,et al. Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable—Prévention Primaire registry , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[11] Panos Vardas,et al. Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial , 2017, American heart journal.
[12] J. Healey,et al. The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patients , 2017, Journal of Interventional Cardiac Electrophysiology.
[13] Philippe Mabo,et al. Rationale and design of the Apixaban for the Reduction of Thrombo‐Embolism in Patients With Device‐Detected Sub‐Clinical Atrial Fibrillation (ARTESiA) trial , 2017, American heart journal.
[14] A. Curnis,et al. Predicting the difficulty of a transvenous lead extraction procedure: Validation of the LED index , 2017, Journal of cardiovascular electrophysiology.
[15] A. Capucci,et al. Can we predict new AF occurrence in single-chamber ICD patients? Insights from an observational investigation. , 2017, International journal of cardiology.
[16] Ulrich Schotten,et al. 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS. , 2017, Revista espanola de cardiologia.
[17] Musab Alqasrawi,et al. Long‐Term Stability and Clinical Utility of Amplified Atrial Electrograms in a Single‐Lead ICD System with Floating Atrial Electrodes , 2016, Pacing and clinical electrophysiology : PACE.
[18] P. Kirchhof,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[19] P. Friedman,et al. Performance of Atrial Fibrillation Detection in a New Single‐Chamber ICD , 2016, Pacing and clinical electrophysiology : PACE.
[20] D. V. van Veldhuisen,et al. 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.
[21] F. Quartieri,et al. Implantable Cardioverter Defibrillator System with Floating Atrial Sensing Dipole: A Single‐Center Experience , 2014, Pacing and clinical electrophysiology : PACE.
[22] C. Murray,et al. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.
[23] Ellen Aagaard Nohr,et al. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark , 2013, European heart journal.
[24] A. Banerjee,et al. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project. , 2013, International journal of cardiology.
[25] Gregory Y H Lip,et al. Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[26] A. Capucci,et al. Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.
[27] L. Eckardt,et al. Comparison of a Novel, Single-Lead Atrial Sensing System With a Dual-Chamber Implantable Cardioverter-Defibrillator System in Patients Without Antibradycardia Pacing Indications: Results of a Randomized Study , 2011, Circulation. Arrhythmia and electrophysiology.
[28] Dongfeng Qi,et al. The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study , 2009, Circulation. Arrhythmia and electrophysiology.
[29] A. Capucci,et al. Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events , 2009, Journal of cardiovascular electrophysiology.
[30] Jacques Victor,et al. Risk Factors Related to Infections of Implanted Pacemakers and Cardioverter-Defibrillators: Results of a Large Prospective Study , 2007, Circulation.
[31] S. Lévy,et al. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. , 2007, American heart journal.
[32] A. Capucci,et al. Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination , 1999, Heart.
[33] G. Nollo,et al. Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. , 1995, Circulation.
[34] N. Kouchoukos,et al. Characterization of Atrial Fibrillation in Man: Studies Following Open Heart Surgery * , 1978, Pacing and clinical electrophysiology : PACE.
[35] Andrea Mazzanti,et al. [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. , 2015, Kardiologia polska.